Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Clinical trial NCT05156060 · RECRUITING

Trial details

NCT number: NCT05156060
Sponsor: Natalie Lockney
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Locally Advanced Head and Neck Carcinoma

Start date: 2022-01-24
Primary completion: 2025-12-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.